Q3 Preliminary 10/23/06 American Oriental Bioengineering, Inc. Announces Preliminary Results for Third Quarter 2006
Monday October 23, 9:24 am ET
-- Company Expects to Report Revenue of Approximately $27 million for Third Quarter and EPS of at least $0.11; Representing 102% and 38% Increase from Last Year
-- Earnings Conference Call Scheduled for November 14, 2006 at 4:45 PM EST to Discuss Final Results
NEW YORK--(BUSINESS WIRE)--American Oriental Bioengineering, Inc. (AMEX: AOB - News), a leading manufacturer and distributor of plant-based pharmaceutical and nutraceutical products in China, today announced preliminary results for the third quarter 2006 and the date for the Company's third quarter conference call to discuss final results.
ADVERTISEMENT
The Company expects to report revenue of approximately $27 million for the third quarter 2006, which would represent a 102 percent increase from the third quarter of last year based on continued strength across all major product lines. AOB expects to report earnings per share of at least $0.11 for the third quarter 2006, which would represent 38 percent increase from last year.
Management will conduct a conference call on November 14, 2006 to announce final third quarter 2006 results. During that time management will provide further financial details in regards to the third quarter.
The conference call will take place at 4:45 p.m. ET. Interested participants should call 888-243-1152 when calling within the United States or 973-582-2868 when calling internationally. There will be a playback available until Nov 21, 2006. To listen to the playback, please call 877-519-4471 when calling within the United States or 973-341-3080 when calling internationally. Please use pass code 8024117 for the replay.
This call is being webcast by ViaVid Broadcasting and can be accessed at American Oriental Bioengineering's Web site at bioaobo.com. The webcast may also be accessed at ViaVid's Web site at www.viavid.net. The webcast can be accessed until December 14, 2006 on either site.
About American Oriental Bioengineering Inc.
American Oriental Bioengineering, Inc. is engaged in the development and production of plant-based pharmaceutical products and plant-based nutraceutical products widely distributed throughout China. For more information, visit bioaobo.com.
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof. |
